A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 53,245 shares of MRK stock, worth $5.22 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
53,245
Previous 75,939 29.88%
Holding current value
$5.22 Million
Previous $9.4 Million 35.69%
% of portfolio
0.23%
Previous 0.39%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $2.52 Million - $2.93 Million
-22,694 Reduced 29.88%
53,245 $6.05 Million
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $2.33 Million - $2.51 Million
-18,845 Reduced 19.88%
75,939 $9.4 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $2.64 Million - $3.08 Million
-23,337 Reduced 19.76%
94,784 $12.5 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $444,699 - $483,939
4,439 Added 3.9%
118,121 $12.9 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $2.54 Million - $2.82 Million
24,696 Added 27.75%
113,682 $11.7 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $477,558 - $520,516
-4,397 Reduced 4.71%
88,986 $10.3 Million
Q1 2023

May 09, 2023

SELL
$102.94 - $114.86 $2.94 Million - $3.28 Million
-28,577 Reduced 23.43%
93,383 $9.94 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $165,174 - $211,775
-1,889 Reduced 1.53%
121,960 $13.5 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $201,773 - $226,669
-2,387 Reduced 1.89%
123,849 $10.7 Million
Q2 2022

Aug 16, 2022

BUY
$83.49 - $94.64 $222,500 - $252,215
2,665 Added 2.16%
126,236 $11.5 Million
Q1 2022

May 17, 2022

SELL
$73.51 - $82.4 $366,373 - $410,681
-4,984 Reduced 3.88%
123,571 $10.1 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $152,077 - $190,496
2,104 Added 1.66%
128,555 $9.85 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $14,192 - $15,608
-198 Reduced 0.16%
126,451 $9.5 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $253,819 - $280,749
-3,610 Reduced 2.77%
126,649 $9.85 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $3.16 Million - $3.72 Million
45,872 Added 54.36%
130,259 $10 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $976,789 - $1.08 Million
13,610 Added 19.23%
84,387 $6.9 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $1.62 Million - $1.83 Million
-22,095 Reduced 23.79%
70,777 $5.87 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $3.96 Million - $4.51 Million
56,255 Added 153.63%
92,872 $7.18 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $3.91 Million - $5.43 Million
-61,782 Reduced 62.79%
36,617 $2.82 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $680,376 - $767,725
-8,770 Reduced 8.18%
98,399 $8.95 Million
Q3 2019

Nov 13, 2019

SELL
$76.08 - $82.93 $29,519 - $32,176
-388 Reduced 0.36%
107,169 $9.02 Million
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $194,225 - $226,901
-2,781 Reduced 2.52%
107,557 $9.02 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $50,306 - $57,377
-723 Reduced 0.65%
110,338 $9.18 Million
Q4 2018

Feb 12, 2019

BUY
$65.24 - $75.71 $264,222 - $306,625
4,050 Added 3.78%
111,061 $8.49 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $38,075 - $44,774
660 Added 0.62%
107,011 $7.59 Million
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $121,483 - $142,730
2,390 Added 2.3%
106,351 $6.46 Million
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $149,312 - $173,543
2,930 Added 2.9%
103,961 $5.66 Million
Q4 2017

Feb 13, 2018

SELL
$51.62 - $61.64 $210,712 - $251,614
-4,082 Reduced 3.88%
101,031 $5.69 Million
Q3 2017

Nov 08, 2017

BUY
$58.67 - $63.13 $6.17 Million - $6.64 Million
105,113
105,113 $6.73 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Meiji Yasuda Asset Management CO Ltd. Portfolio

Follow Meiji Yasuda Asset Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Asset Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Asset Management CO Ltd. with notifications on news.